[1］Yamaguchi T.Lipid microspheres as drug carriers:a pharmaceutical point of view［J］. Adv Dru Deli Rev ，1996,20:117. [2］Igarashi R, Takenaga M, Matsuda T.Distribution of lipid microsphere preparation ［J］. Adv Dru Deli Rev ，1996,20:147. [3］Magalhaes NSS, Cave G, Seiller M, et al .The stability and in vitro release kinetics of a clofibride emulsion［J］. Int J Pharm ，1991,76:225. [4］Johnson OL, Washington C, Davis SS.Long-term stability of fluorocarbon oxygen transport emulsions［J］. Int J Pharm ，1990,63:65. [5］Jumma M, Mueller BW. The stabilization of parenteral fat emulsion using nonionic ABA copolymer surfactant［J］. Int J Pharm ，1998,174:29. [6］Wheeler JJ, Wong KF, Ansell SM, et al . Polyethylene glycol modified phospholipids stabilize emulsions prepared from triacylglycerol［J］. J Pharm Sci ，1994,83:1558. [7］Levy MY, Schutze W, Fuhrer C, et al .Characterization of diazepam submicron emulsion interface: role of oleic acid［J］. J Microencapsulation ，1994,11:79. [8］Washington C. Stability of lipid emulsions for drug delivery［J］. Adv Dru Deli Rev ，1996,20:131. [9］Jumaa M, Kleinebudde P, Mueller BW. Physicochemical properties and hemolytical effect of different lipid emulsion formulations using a mixture of emulsifiers［J］. Pharm Acta Helvetiae ，1999,73:293 . [10］Jumaa M, Mueller BW. Physicochemical properties of chitosan-lipid emulsions and their stability during the autoclaving process［J］. Int J Pharm ，1999,183:175. [11］Schwarz C, Mehnert W, Lucks JS, et al . Solid lipid nanoparticles (SLN) for controlled drug delivery.ⅠProduction, characterization and sterilization［J］. J Controlled Release ，1994,30:83. [12］Yamamura K, Nakao M, Yano K, et al . Stability of forskolin in lipid emulsions and oil/water partition coefficients ［J］. Chem Pharm Bull ，1991,39:1032 . [13］Yamaguchi T, Nishizaki K, Hai S, et al .Physicochemical characterization of parenteral lipid emulsion: influence of cosurfactants on flocculation and coalescence［J］. Pharm Res ，1995,12:1273. [14］Teagarden DL, Anderson BD, Petre WJ.The distribution and chemical kinetics of prostaglandin E1 in lipid emulsions［J］. Adv Dru Deli Rev ，1996,20:155. [15］Washington C, Davis SS. Aging effects in parenteral fat emulsions:the role of fatty acids［J］. Int J Pharm ，1987,39:33. [16］Herman CJ, Groves MJ. The influence of free fatty acid formation on the pH of phospholipid-stabilized triglyceride emulsion［J］. Pharm Res ，1993,10:774. [17］Zuidam NJ, Lee SSL, Crommelin DJA. Sterilization of liposomes by heat treatment［J］. Pharm Res ，1992,10:1591. [18］Washington C.Evaluation of non-sink dialysis methods for the measurement of drug release from colloids: effect of drug partition［J］. Int J Pharm ，1989,56:71. [19］Yamaguchi T，Tanabe N, Fukushima Y, et al . Distribution of prostaglandin E1 in lipid emulsion in relation to release rate from lipid particles［J］ .Chem Pharm Bull ，1994,42:646. [20］Sim AK, McCraw AP, Cleland ME, et al .A preclinical assessment of the effect of lipo-PGE1 on thrombus formation and thrombus disaggregation［J］. Adv Dru Deli Rev ，1996,20:165. [21］Tahenaga M.Application of lipid microspheres for the treatment of cancer［J］. Adv Drug Deli Rev ，1996,20:209. [22］李喜荣，蔡美英．靶向给药系统内化机理的研究进展［J］．国外医学·药学分册，2000,27:35. [23］Venikatesh S, Li J, Caldwell KD, et al . Compositional heterogeneity in parenteral lipid emulsions after sedimentation field flow fractionation［J］. J Pharm Sci ，1998,87:859. [24］Hoshi K.Approved indications of lipo-PGE1 in Japan［J］. Adv Dru Deli Rev ，1996,20:171. [25］Ohmukai O.Lipo-NSAID preparation［J］. Adv Dru Deli Rev ，1996,20:203. [26］Lundberg B.The solubilization of lipophilic derivatives of podophyllotoxins in submicron sized lipid emulsions and their cytotoxic activity against cancer cells in culture［J］. Int J Pharm ，1994,109:73. [27］Washington C.The stability of intravenous fat emulsion in total parenteral nutrition mixtures［J］. Int J Pharm ，1990,66:1～21. [28］Lee MJ, Lee MH,Shim CK.Inverse targeting of drugs to reticuloendothelial system-rich organs by lipid microemulsion emulsified with poloxamer 338［J］. Int J Pharm ，1995,113:175 . [29］Hodoshima N, Udagawa C, Ando T, et al .Lipid nanoparticles for delivering antitumor drugs［J］. Int J Pharm ，1997,146:81. [30］Wang Y,Cory AL.A novel stable supersaturated submicron lipid emulsion of tirilazad［J］. Pharm Dev Tech ，1999,4:333.